Xenous Holdings, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
Xenous Holdings, Inc. filed its quarterly report, revealing no revenue, increasing losses, and significant doubt about its ability to continue as a going concern.
OTC.Pink
Xenous Holdings, a company with no current operations, reported a net loss for Q2 2025 and faces substantial doubt about its ability to continue as a going concern, despite progress on a potential acquisition.
OTC.Pink
Xenous Holdings, Inc. reported continued net losses and a growing accumulated deficit for Q2 2025, with no business operations or revenue.
OTC.Pink
Xenous Holdings, Inc. reports ongoing net losses and a working capital deficit in its Q3 2025 10-Q filing, raising concerns about its ability to continue as a going concern.
OTC.Pink
Xenous Holdings, a company with no current business operations, reported a net loss of $31,155 and a working capital deficit of $870,321 for the six months ended September 30, 2024.
OTC.Pink
10-Q: Xenous Holdings Reports Q1 2025 Results: Net Loss Continues Amidst Ongoing Acquisition Efforts
Xenous Holdings, a company with no current business operations, reported a net loss of $15,971 for the quarter ended June 30, 2024, while continuing due diligence on a potential acquisition.
OTC.Pink
Xenous Holdings, a company with no current business operations, reported a net loss of $45,462 and a working capital deficit of $820,882 for the nine months ended December 31, 2023.